Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily
Question:
Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc.’s second year of operations.
Pain Reliever | Weight Loser | |
R&D expenditures (second year) | $450,000 | $300,000 |
After-tax income | 275,000 | $210,000 |
Current liabilities | 584,000 | 397,000 |
Divisional investment | 1,365,000 | 982,000 |
Cost of capital | 23% | 23% |
In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending.
Required:
Calculate EVA for the two divisions of Pharma Inc. for its second year of operations.
Financial Accounting Tools for business decision making
ISBN: 978-0470534779
6th Edition
Authors: Paul D. Kimmel, Jerry J. Weygandt, Donald E. Kieso